Atossa Therapeutics Inc. (ATOS) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Atossa Therapeutics Inc.

    NASDAQ: ATOS · Real-Time Price · USD
    0.83
    0.01 (0.83%)
    At close: Sep 11, 2025, 3:59 PM

    Atossa Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 17K 23K 8K 23K
    Gross Profit
    		 -17K -23K -8K -23K
    Operating Income
    		 -27.62M -31.38M -27.69M -20.52M
    Interest Income
    		 4.05M 4.34M 877K 6K
    Pretax Income
    		 -25.5M -30.09M -26.96M -20.61M
    Net Income
    		 -25.5M -30.09M -26.96M -20.61M
    Selling & General & Admin
    		 13.49M 14.04M 12.61M 11.31M
    Research & Development
    		 14.12M 17.33M 15.08M 9.21M
    Other Expenses
    		 n/a n/a n/a n/a
    Operating Expenses
    		 27.6M 31.38M 27.69M 20.52M
    Interest Expense
    		 n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 -27.62M 31.38M 27.69M 20.52M
    Income Tax Expense
    		 n/a n/a n/a n/a
    Shares Outstanding (Basic)
    		 125.86M 126.08M 126.62M 116.95M
    Shares Outstanding (Diluted)
    		 125.86M 126.08M 126.62M 116.95M
    EPS (Basic)
    		 -0.2 -0.24 -0.21 -0.18
    EPS (Diluted)
    		 -0.2 -0.24 -0.21 -0.18
    EBITDA
    		 -25.49M -31.35M -27.68M -20.5M
    EBIT
    		 -25.5M -31.38M -27.69M -20.52M
    Depreciation & Amortization
    		 17K 23K 8K 23K

    Add to Watchlist